how long does glp-1 stay in your system after stopping for to Leave System: Elimination Timeline How long do you have

Phase II clinical trial results demonstrated: Body weight reduction of up to 2% at 48 weeks ( vs 2.1% placebo ) 83% of participants achieved 15% body weight loss at highest dose HbA1c reduction of up to 02% in Type 2 Diabetes participants ( vs 0% placebo ) Normalization of liver fat in 86% of participants with hepatic steatosis Reduction in systolic blood pressure averaging 6-8 mmHg These Phase II findings are preliminary

Source: Eli Lilly press release, December 11, 2025

Research Applications Metabolic regulation and energy balance research Adiposity and body composition in animal research models GLP-1, GIP, and glucagon receptor interaction studies Insulin secretion and glucose homeostasis research Hepatic fat reduction and liver function studies Cardiovascular metabolic research Comparison studies vs

Are there any side effects of Retatrutide